Conflict of Interest (Research)
A situation where a researcher's financial or personal interests could potentially influence the design, conduct, or interpretation of a study. Disclosing conflicts of interest (such as pharmaceutical company funding or consulting relationships) is an ethical requirement in scientific publishing.
Technical Context
Financial COI types: direct employment by pharmaceutical company, consulting fees, speaker honoraria, research grants, equity/stock ownership, patent royalties, and expert testimony fees. Non-financial COI: academic advancement pressure, intellectual commitments to a hypothesis, and personal relationships. ICMJE (International Committee of Medical Journal Editors) requires standardised COI disclosure forms with all manuscript submissions. Studies sponsored by pharmaceutical companies show larger effect sizes on average than independently funded studies (known as the funding effect). Cochrane Reviews assess funding source as a potential risk of bias factor. Clinical practice guideline committees increasingly require majority independent (non-conflicted) membership and transparent management of members with COI. For peptide drug publications, disclosing industry relationships is essential for readers to assess potential bias.